艾滋病毒感染者的潜在长期结核病治疗:成本效益基准
Amy Zheng1, Eden Pletner2, Keren Middelkoop3,4
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY, United States.
Annals of the American Thoracic Society
|February 21, 2026
概括
一种新的长效注射结核病治疗方法显示,它有望改善南非的结核病治疗结果. 这种方法具有成本效益,特别是当患者脱离标准口服治疗时,这种方法是高的.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 卫生经济学 卫生经济学
背景情况:
- 在南非,结核病 (TB) 治疗结果受到高艾滋病毒共感染率和患者流失的阻碍.
- 长效结核病药物具有潜在的益处,但需要仔细评估成本效益.
研究的目的:
- 确定长效结核病治疗在临床上是有益的,并且与标准口服治疗相比更具成本效益的场景,用于南非艾滋病毒感染者.
- 分析疗效,成本和患者脱离对长期结核病治疗的成本效益的影响.
主要方法:
- 一个微模拟模型将6个月的口服结核病治疗 (SOC) 与长效治疗 (LA) 方案 (口服治疗2个月 + 一次注射) 的标准护理相比较.
- 模型参数包括疗效,每月退出率,结核病复发率和总治疗费用.
- 成本效益被定义为增量成本效益比率 (ICER) <每年生命节省的3000美元 (YLS).
主要成果:
- 与SOC相比,LA战略显示了较低的全因死亡率 (11.4%vs11.6%) 和减少脱离 (12.9%vs20.9%).
- 在24个月 (ICER $2,230/YLS) 和终身视野 (ICER $520/YLS) 的基准案例模拟中,LA是具有成本效益的.
- 在整个生命周期的单向灵敏度分析中,LA在所有评估的参数范围中仍然具有成本效益.
结论:
- 在特定条件下,长效的注射性结核病治疗与传统的口服治疗相比,可能具有成本效益.
- 高效率和合理的成本可以实现成本效益,特别是当从标准口服结核病治疗中脱离时是高的.
相关概念视频
01:28Pulmonary Tuberculosis V
663
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
663
01:26Pulmonary Tuberculosis IV
560
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
560
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:28Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
01:31Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
01:29Therapeutic Drug Monitoring: Affecting Factors
266
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
266